1. Home
  2. BRN vs CTXR Comparison

BRN vs CTXR Comparison

Compare BRN & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRN
    SELLHOLDBUYas of 16 hours ago
  • CTXR
    SELLHOLDBUYas of 16 hours ago
  • Stock Information
  • Founded
  • BRN 1956
  • CTXR 2007
  • Country
  • BRN United States
  • CTXR United States
  • Employees
  • BRN N/A
  • CTXR N/A
  • Industry
  • BRN Oil & Gas Production
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRN Energy
  • CTXR Health Care
  • Exchange
  • BRN Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • BRN 17.6M
  • CTXR 14.6M
  • IPO Year
  • BRN N/A
  • CTXR N/A
  • Fundamental
  • Price
  • BRN $1.49
  • CTXR $0.98
  • Analyst Decision
  • BRN
  • CTXR Strong Buy
  • Analyst Count
  • BRN 0
  • CTXR 2
  • Target Price
  • BRN N/A
  • CTXR $54.50
  • AVG Volume (30 Days)
  • BRN 15.3K
  • CTXR 629.7K
  • Earning Date
  • BRN 05-13-2025
  • CTXR 05-13-2025
  • Dividend Yield
  • BRN N/A
  • CTXR N/A
  • EPS Growth
  • BRN N/A
  • CTXR N/A
  • EPS
  • BRN N/A
  • CTXR N/A
  • Revenue
  • BRN $20,046,000.00
  • CTXR N/A
  • Revenue This Year
  • BRN N/A
  • CTXR N/A
  • Revenue Next Year
  • BRN N/A
  • CTXR N/A
  • P/E Ratio
  • BRN N/A
  • CTXR N/A
  • Revenue Growth
  • BRN N/A
  • CTXR N/A
  • 52 Week Low
  • BRN $1.26
  • CTXR $0.95
  • 52 Week High
  • BRN $3.20
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • BRN 37.55
  • CTXR 27.13
  • Support Level
  • BRN $1.47
  • CTXR $0.95
  • Resistance Level
  • BRN $1.79
  • CTXR $2.28
  • Average True Range (ATR)
  • BRN 0.08
  • CTXR 0.21
  • MACD
  • BRN -0.02
  • CTXR -0.01
  • Stochastic Oscillator
  • BRN 6.25
  • CTXR 1.96

Stock Price Comparison Chart: BRN vs CTXR

BRN
CTXR
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April02468101214161820222426BRN VS CTXR

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use